Maine 2025-2026 Regular Session

Maine House Bill LD926

Introduced
3/5/25  

Caption

An Act to Promote Research and Development in the State by Amending the Research Expense Tax Credit

Impact

If enacted, LD926 would have a substantial impact on state laws pertaining to business taxation and support for innovation. The bill sets specific performance measures for evaluating the effectiveness of the tax credit, focusing on factors such as the growth in research and development investments and the creation of high-wage jobs in the state. Additionally, it mandates annual reporting on the effectiveness of the credit, ensuring accountability and transparency in the administration of this financial incentive.

Summary

Legislative Document 926, titled 'An Act to Promote Research and Development in the State by Amending the Research Expense Tax Credit', aims to enhance the state's research and development landscape through significant changes to the existing tax credit structure. This bill proposes to increase the amount of expenditures eligible for the research expense tax credit, effectively doubling the rate at which the credit is calculated and the maximum claimable amount. By doing so, the legislators seek to stimulate investment in research activities that are crucial for economic growth and job creation within the state.

Sentiment

The sentiment surrounding LD926 appears largely positive among proponents who view it as a necessary step toward supporting businesses involved in research and development. Advocates argue that the enhanced tax credits will not only lead to increased investment within the state but also attract and retain high-quality jobs capable of bolstering the local economy. However, there may be caution expressed by some groups regarding the fiscal implications of expanding tax credits in an uncertain economic climate.

Contention

Notable points of contention regarding LD926 can arise around the effectiveness and sustainability of increased tax credits. Critics may argue that while the intention to boost research and development is commendable, such financial incentives could lead to significant revenue losses for the state. Opposition voices could raise concerns over whether tax credits translationally translate into actual investments and job creation, calling for careful monitoring and evaluation of the bill's outcomes once implemented.

Companion Bills

No companion bills found.

Previously Filed As

ME LD643

An Act to Promote Research and Development in the State by Increasing the Research Expense Tax Credit

ME LD1918

An Act to Modernize Maine's Business Incentive Programs by Creating the Dirigo Business Incentives Program and Eliminating Certain Other Tax Incentive Programs

ME LD1475

An Act to Establish a Grant Program to Promote Biomanufacturing and Biotechnology Development

ME LD2258

An Act to Create an Income Tax Credit for Investments in a Team's Qualified Minor League Baseball Facility to Keep the Team in the State

ME LD1467

An Act to Establish the Maine Cannabis Research Committee and Facilitate Research into Alternative Therapeutics

ME LD1804

An Act to Improve the Reporting Process for Certain Tax Expenditure Programs

ME LD1544

An Act to Improve Economic Security for Maine Children by Amending the Maine Dependent Exemption Tax Credit

ME LD416

An Act to Authorize a General Fund Bond Issue for Research and Development and Commercialization

ME LD2214

An Act to Make Supplemental Appropriations and Allocations for the Expenditures of State Government, General Fund and Other Funds and to Change Certain Provisions of the Law Necessary to the Proper Operations of State Government for the Fiscal Years Ending June 30, 2024 and June 30, 2025

ME LD258

An Act Making Unified Appropriations and Allocations from the General Fund and Other Funds for the Expenditures of State Government and Changing Certain Provisions of the Law Necessary to the Proper Operations of State Government for the Fiscal Years Ending June 30, 2023, June 30, 2024 and June 30, 2025

Similar Bills

CA AB922

Reproductive health and research: oocyte procurement.

HI SB2304

Relating To The Research Corporation Of The University Of Hawaii.

HI SB3208

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1511

Relating To The Research Corporation Of The University Of Hawaii.

HI SB1204

Relating To The University Of Hawaii.

CA SB934

California Childhood Cancer Research Fund Act.

CA AB1103

Controlled substances: research.